The following are pre-publication drafts of articles from the
Morbidity and Mortality Weekly Report 44(04) dated Friday, February 3,
1995.  Late-breaking articles, and final editorial revisions are not
included.  Therefore, these articles should not be quoted without
consulting the official printed copy that is released to the public,
as received from the CDC.  Also, please refer to the printed copy for
any charts or graphically represented data.

       Table of Contents
       -----------------

       Current Trends: Occupational Silicosis -- Ohio, 1989-1994
       Current Trends: Update: Acquired Immunodeficiency Syndrome --
            United States, 1994
       Current Trends: Acute Pulmonary Hemorrhage Among Infants --
            Chicago, April 1992-November 1994
       Epidemiologic Notes and Reports: Transmission of Pertussis from Adult
            to Infant -- Michigan, 1993
       Current Trends: Controlling Lead Toxicity in Bridge Workers --
            Connecticut, 1991-1994
       Erratum: Vol. 44, No. 3

       -----------------

       Current Trends
       Occupational Silicosis -- Ohio, 1989-1994

       Silicosis is a chronic lung disease associated with the
inhalation and pulmonary deposition of dust that contains crystalline
silica. Through the Sentinel Event Notification System for
Occupational Risks (SENSOR)* program, CDC's National Institute for
Occupational Safety and Health (NIOSH) is assessing practical models
for implementing state-based surveillance of silicosis and linking
follow-up intervention activities to surveillance reports. From 1989
through 1992, the Ohio Department of Health (ODH) SENSOR program
identified silicosis cases through reports of Bureau of Workers'
Compensation (BWC) claims, physician reports, and death certificates.
The addition in 1993 of hospital discharge reports as an ascertainment
source resulted in a substantial increase in the number of silicosis
case reports identified annually (Table 1). This report describes the
investigation of a case of occupational silicosis in Ohio and
summarizes the impact of hospital-based reporting on surveillance for
silicosis in Ohio during 1993-1994. Case Report

       In September 1991, a case report** was sent to ODH by an
infectious disease specialist who was treating a 55-year-old
sandblaster with advanced silicosis and an associated Mycobacterium
kansasii infection*** (2). In January 1992, NIOSH and ODH conducted a
joint investigation at the worker's place of employment--a metal
preparation shop--to evaluate current levels of exposure to respirable
crystalline silica and to screen co-workers for silicosis. The
investigation detected excessive exposures to respirable crystalline
silica (2-5). Chest radiology revealed radiographic abnormalities
consistent with pneumoconiosis in four of 16 current and former
workers (including one case of advanced silicosis [International
Labour Organization, category C (6)]). At the time of the initial
survey, ODH recommended that the company discontinue use of silica
sand in abrasive blasting operations. In March 1992, the company
substituted aluminum oxide for silica sand in all abrasive blasting
operations. Direct Hospital Discharge Reporting

       In February 1993, ODH designated silicosis as a disease
warranting special assessment; although not requiring reporting by
hospitals, this designation authorized ODH surveillance staff to gain
access to medical records of persons with potential cases. In April
1993, ODH notified all general (i.e., nonpediatric and nonpsychiatric)
hospitals by mail about this designation and requested copies of
medical records of all patients who had been discharged since March
1991 with a primary or secondary diagnosis coded as "Pneumoconiosis
due to silica or silicates" (International Classification of Diseases,
Ninth Revision [ICD-9], code 502). In response, hospitals sent the
discharge records of 262 suspected silicosis cases for the period
covered by the initial request (through 1993); ODH determined that 257
(98%) of these were unique cases that did not duplicate cases reported
by the other sources (Table 1). An additional 147 cases (all of which
were unique reports) were forwarded by hospitals during 1994 in
response to a similar request mailed in March 1994. For 1993-1994, OHD
received a total of 404 suspected silicosis cases that were reported
only by hospitals; all other sources combined reported a total of 24
cases during these 2 years.

       Of the 404 hospital-based reports, 99 (24%) were confirmed****
as silicosis using information contained in the hospital records and,
for some cases, direct contacts with discharged patients. An
additional 69 (17%) cases met the objective medical criterion
specified in the silicosis surveillance case definition; however,
final confirmation for these is pending verification of a history of
occupational exposure to airborne silica dust.

Reported by: E Socie, MS, A Migliozzi, MSN, S Wagner, MPH, TJ Halpin,
MD, State Epidemiologist, Ohio Dept of Health. Epidemiological
Investigations Br, Div of Respiratory Disease Studies, National
Institute for Occupational Safety and Health, CDC.

Editorial Note: The findings in this report demonstrate the
potentially crucial role of direct hospital discharge reporting in
surveillance for silicosis. In particular, compared with other
information sources (e.g., computerized death certificate reviews and
reports of BWC claims), advantages of hospital discharge-based
reporting for silicosis are 1) case reports are submitted to ODH on a
more timely basis--an action that is necessary to enable follow-up
investigations, such as that described in this report, and 2) this
source enables the provision of clinical information that is necessary
for case confirmation. Although reports from physicians also are
similarly useful, hospitals are more likely than physicians to report
cases.

       Other states have used direct hospital discharge reporting for
surveillance for occupational asthma (7). Because occupational-related
information is usually not included in hospital medical records, a
phone interview is conducted with persons with identified cases to
determine if the condition was work related. This approach to case
identification may be useful for other conditions (e.g., asbestosis
and coal workers' pneumoconiosis).

       Hospital discharge data-based reporting for silicosis is
subject to at least three limitations. First, most persons with
silicosis are not hospitalized at the time of initial diagnosis and,
therefore, will not be identified by hospital-based reporting during
early stages of disease. Second, silicosis may not be entered as a
discharge diagnosis if it is an incidental diagnosis and not a primary
reason for hospitalization or if it is not mentioned in the patient's
past medical history. Third, Ohio has no mechanism to assess
completeness of direct hospital discharge reporting. Because of these
limitations and to ensure complete case ascertainment, a comprehensive
surveillance system for silicosis should employ other methods,
including workers' compensation claim data, death certificate data,
and direct physician reports.

       In addition to Ohio, four other states (Illinois, Michigan, New
Jersey, and Wisconsin) use hospital discharge data for silicosis
surveillance; programs in Illinois and Wisconsin rely on voluntary
direct reporting by physicians and hospitals while programs in
Michigan and New Jersey mandate direct reporting by physicians and
hospitals. In Illinois, Michigan, and New Jersey, computerized
hospital discharge data also are reviewed annually, and investigation
of discrepancies between cases identified through direct discharge
reporting and through the review of computerized hospital discharge
data tapes has enabled these states to improve ascertainment of cases
and to assess underreporting by hospitals.

       An important goal of the SENSOR projects for silicosis is to
develop a model of silicosis surveillance that can be implemented in
any state that has targeted the prevention of silicosis. Other
conditions targeted by SENSOR include asthma, tuberculosis, burns,
amputations, cadmium overexposure, carpal tunnel syndrome, childhood
injuries, dermatitis, noise-induced hearing loss, pesticide health
effects, and spinal cord injuries. Such systems most likely will
require the use of multiple data sources for comprehensive case
ascertainment.

       References

       1. CDC. Silicosis: cluster in sandblasters--Texas, and
occupational surveillance for silicosis. MMWR 1990;39:433-7.

       2. Liston R. Silica survey report. Columbus Ohio: Ohio
Department of Health, March 1992. (Computer no. 12292).

       3. NIOSH. Health hazard evaluation report: commercial steel
treating company. Cincinnati: US Department of Health and Human
Services, Public Health Service, CDC, 1992; DHHS publication no.
(NIOSH)92-0174-2363.

       4. NIOSH. Request for assistance in preventing silicosis and
deaths from sandblasting. Cincinnati: US Department of Health and
Human Services, Public Health Service, CDC, 1992; DHHS publication no.
(NIOSH)92-102.

       5. Short S, Liston R, O'Brien D, Migliozzi N, Wagner G, Parker
J. Silico-tuberculosis death in a sandblaster: the utility of the
Sentinel Event Notification System for Occupational Risks (SENSOR)
program. Am Rev Respir Dis 1993;147:4:A898.

       6. International Labour Office. Guidelines for the use of ILO
International Classification of Radiographs of pneumoconioses. Revised
ed. Geneva: International Labour Office, 1980:6-7. (Occupational
safety and health series 22 [Rev.80]).

       7. CDC. Surveillance for occupational asthma--Michigan and New
Jersey, 1988-1992. In: CDC surveillance summaries (June). MMWR
1994;43(no. SS-1):9-17.

          * SENSOR is a program of cooperative agreements with state
            health departments to develop surveillance and
            intervention strategies for selected occupational
            conditions. The National Institute for Occupational Safety
            and Health currently supports SENSOR silicosis programs in
            seven states (Illinois, Michigan, New Jersey, North
            Carolina, Ohio, Texas, and Wisconsin).

         ** Case reports should be submitted for persons with a
            physician's provisional diagnosis of silicosis, a chest
            radiograph interpreted as consistent with silicosis, or
            pathologic findings consistent with silicosis (1).

        *** Silicosis is often complicated by severe Mycobacterium
            infections (e.g., M. tuberculosis, M. kansasii, and M.
            avium complex).

       **** Case confirmation requires 1) a history of occupational
            exposure to airborne silica dust (exposure criterion) and
            2) either a chest radiograph consistent with silicosis or
            pathologic findings characteristic of silicosis (medical
            criterion) (1).


       Current Trends
       Update: Acquired Immunodeficiency Syndrome -- United States,
       1994

       During 1994, state, local, and territorial health departments
reported to CDC 80,691 cases of acquired immunodeficiency syndrome
(AIDS) among persons in the United States, which followed the 106,618
cases reported in 1993. The number of cases reported in each of these
years was greater than that reported in 1992 (47,572) and followed the
expansion of the AIDS surveillance case definition for adolescents and
adults implemented on January 1, 1993 (1-3). Based on analyses using
consistent definitions, the rate of AIDS-related illnesses increased
3% in 1993 compared with 1992; a similar increase is expected for 1994
compared with 1993 (3). This report summarizes the characteristics of
AIDS cases reported in 1994 and compares these findings with those in
1993.

       Of the total 80,691 reported cases, 79,674 (99%) occurred among
adolescents and adults (i.e., persons aged greater than or equal to 13
years) and 1017 among children aged less than 13 years. Women, blacks
and Hispanics, and persons in the South and Northeast accounted for
higher percentages of reported cases during 1994 than during 1993
(Table 1). Among cases for which risks were reported, the largest
decline in the proportion of reported cases occurred among
homosexual/bisexual men.

       The number of cases reported among adolescents and adults for
1994 (79,674) was lower than that reported for 1993 (105,676). During
1993, the number of cases reported among adolescents and adults
decreased by quarter year of report and included 36,208 during the
first quarter, 25,548 during the second quarter, 25,509 during the
third quarter, and 18,411 during the fourth quarter. In comparison,
the number of cases reported during 1994 varied less by quarter year
of report and included 20,682 during the first quarter, 19,566 during
the second quarter, 21,924 during the third quarter, and 17,502 during
the fourth quarter.

       Of all AIDS cases reported among adolescents and adults during
1994, a total of 43,226 (54%) was reported based on the reporting
criteria added to the definition in 1993. Of these, 39,513 (91%)
persons had severe human immunodeficiency virus (HIV)-related
immunodeficiency only (i.e., less than 200 CD4+ T-lymphocytes per uL
or a CD4+ T-lymphocyte percentage of total lymphocytes less than 14),
2357 (5%) had pulmonary tuberculosis (TB), 1239 (3%) had recurrent
pneumonia, and 164 ( less than 1%) had invasive cervical cancer; 47
persons were reported with greater than or equal to 2 of these
clinical diseases. Of the 3713 persons reported with one of the three
opportunistic illnesses (i.e., pulmonary TB, recurrent pneumonia, and
invasive cervical cancer), 1097 (30%) were women, 2237 (60%) were
black, and 1785 (48%) were injecting-drug users.

       The AIDS surveillance definition for children aged less than 13
years did not change in 1993. The number of cases reported in children
during 1994 (1017) increased 8% over those reported during 1993 (942).
Of the 1017 children, 50% were female, most were black (62%) or
Hispanic (23%), and 92% were infected through perinatal transmission.

Reported by: Local, state, and territorial health depts. Div of
HIV/AIDS, National Center for Infectious Diseases, CDC.

Editorial Note: This report confirms the predicted decline in the
number of AIDS cases reported in 1994 compared with 1993 (2).
Following the expansion of the surveillance definition on January 1,
1993, a substantial increase occurred in the number of cases reported,
predominantly reflecting the reporting of persons with conditions
diagnosed before that date and who were not eligible for reporting
until these conditions were added to the surveillance definition.
However, after these cases had been reported, the number of reported
cases began to decrease by quarter, and during 1994, the numbers of
cases reported by quarter were relatively stable.

       The findings for 1994 indicate a continuation of trends for
certain population groups, including an increase in the proportion of
cases accounted for by women and racial/ethnic minorities, a decrease
in the proportion accounted for by homosexual/bisexual men, and an
increase in the number of cases in children. These patterns may
reflect the evolution of the HIV epidemic but also may have been
influenced by the differential effects of the expansion of the
surveillance definition among different populations and in different
geographic areas (4). Studies are in progress to evaluate the effects
of use of the 1993 criteria on AIDS case reporting.

       The large increases in case reporting associated with the
expansion of the AIDS surveillance definition have constrained the
usefulness of analyses based on year of report as an approach for
monitoring trends. Instead, analyses based on the year of
diagnosis--with adjustments for delays in reporting--typically have
been used to more precisely monitor temporal changes in AIDS trends.
Because most HIV-infected persons develop severe immunosuppression
before the onset of AIDS-defining opportunistic illnesses (AIDS-OIs),
the inclusion of the CD4+ reporting criteria in the surveillance
definition has required an additional adjustment to estimate when
persons who were reported using the CD4+ criteria will develop an
AIDS-OI. Based on these methods, the estimated number of persons with
diagnosed AIDS-OIs in 1993 increased 3% over 1992 (3) and indicated
disproportionate increases for women and racial/ethnic minorities and
a leveling of cases diagnosed among homosexual/bisexual men (CDC,
unpublished data, 1994). Initial analysis suggests that the number of
AIDS-OI diagnoses in 1994 will increase at a rate similar to that
estimated for 1993.

       Use of the expanded AIDS surveillance case definition has been
associated with predicted changes (i.e., both anticipated increases
and decreases) in AIDS case reporting during 1993-1994. However, the
rate of reporting of AIDS remained high in 1994. The approximately
81,000 persons reported with AIDS represent 18% of the 441,528
cumulative AIDS cases reported since 1981. As a result of the
expanding epidemic of severe HIV disease, in 1993 HIV became the
leading cause of death among persons aged 25-44 years (5).

       References

       1. CDC. 1993 Revised classification system for HIV infection
and expanded surveillance case definition for AIDS among adolescents
and adults. MMWR 1992;41(no. RR-17).

       2. CDC. Update: impact of the expanded AIDS surveillance case
definition for adolescents and adults on case reporting--United
States, 1993. MMWR 1994;43:160-1,167-70.

       3. CDC. Update: trends in AIDS diagnosis and reporting under
the expanded surveillance definition for adolescents and
adults--United States, 1993. MMWR 1994;43:826-31.

       4. CDC. Assessment of laboratory reporting to supplement active
AIDS surveillance--Colorado. MMWR 1993;42:749-52.

       5. NCHS. Annual summary of births, marriages, divorces, and
deaths: United States, 1993. Hyattsville, Maryland: US Department of
Health and Human Services, Public Health Service, CDC, 1994:18-20.
(Monthly vital statistics report; vol 42, no. 13).


       Current Trends
       Acute Pulmonary Hemorrhage Among Infants -- Chicago, April
       1992-November 1994

       A cluster of cases of acute pulmonary hemorrhage of unknown
etiology occurred among eight infants in Cleveland during January
1993-November 1994 (1). During the investigation of these cases, a
similar cluster was identified in the Chicago area. From April 1992
through November 1994, seven infants with acute pulmonary hemorrhage
of unknown etiology were admitted to hospitals in the Chicago area.
Four of the infants were treated at the same hospital in which, during
the preceding 3 years (1989-1991), one case of pulmonary hemorrhage
among infants had been diagnosed. This report summarizes the
preliminary results of the ongoing epidemiologic, clinical, and
laboratory investigations of these cases by pediatric pulmonologists
in Chicago, the Illinois Department of Public Health, the Chicago
Department of Public Health, the Cook County Department of Public
Health, and CDC.

       A surveillance case definition for acute pulmonary hemorrhage
among infants that was established by CDC and public health officials
in Chicago is the occurrence in an infant aged less than 1 year of
hemoptysis and/or epistaxis or blood obtained from endotracheal tube
following atraumatic intubation, not attributed to cardiac or vascular
malformations, infectious processes, or known trauma.

       The two infants with the most recently diagnosed cases had been
admitted to separate hospitals in October and November 1994. A review
of medical records identified two additional infants hospitalized in
1992 (in April and December) and three in 1993 (in March, May, and
September). At the time of admission, all seven infants were afebrile
but had anemia and histories consistent with either hemoptysis (four
infants), epistaxis (one), or blood from the endotracheal tube (two).
In addition, acute onset of severe respiratory distress was diagnosed
in all seven at the time of admission.

       Six infants were black and four were male. At the time of
hospitalization, the infants were aged 3 weeks-8 months (mean: 12.3
weeks). All infants were healthy previously. One infant, a twin, had
been delivered at 34 weeks. Six had been delivered at full term
without complications. Six infants had been fed cow's-milk-based
formulas, and one had been breastfed. The residences of the infants
were dispersed in an approximately 40-square-mile area.

       Because of the severity of respiratory distress, all seven
infants were admitted to pediatric intensive-care units and were given
respiratory support by mechanical ventilation. Duration of mechanical
ventilation ranged from 4 to 12 days (mean: 8 days). On admission,
mean hematocrit was 26.2% (range: 17.0%-30.5% [normal: 36.0%-47.0%]),
and mean hemoglobin was 7.9 mg/dL (range: 5.0 mg/dL- 9.6 mg/dL
[normal: 10.0-15.0 mg/dL]). Red blood cell morphology (anisocytosis
and 1+ schistocytosis) suggested mild hemolysis. For all seven
infants, platelet counts were normal, and findings were within normal
limits for prothrombin time and partial thromboplastin time. White
blood cell counts ranged from 7.0 cells/mm superscript 3 to 26.1
cells/mm superscript 3 (mean=14.3 cells/mm superscript 3). All seven
infants received blood transfusions for anemia.

       Chest radiographs within 24 hours of admission indicated
bilateral alveolar infiltrates in all seven infants. Bronchoscopy was
performed for all seven infants to identify the source of bleeding,
but no source was detected. Gastrointestinal evaluations (i.e.,
endoscopies and abdominal computerized axial tomography scans)
performed for four of the infants also did not detect a source of
bleeding. Evaluations of two of the infants for allergies to cow's
milk protein through quantification of milk precipitins were negative.

       Cultures of blood and urine specimens were negative for
bacterial, mycotic, and viral pathogens. Cultures of tracheal
aspirates were positive in one infant and yielded Serratia marcessens
and Staphylococcus aureus. Twelve days after admission, respiratory
syncytial virus was isolated from tracheal aspirates from one infant,
but she was discharged with a diagnosis of idiopathic pulmonary
hemosiderosis.

       After receiving antibiotics and other supportive care, all
seven infants fully recovered and were discharged. One infant died 3
weeks after discharge; lung biopsy and immunologic, gastrointestinal,
and infectious disease evaluations of this infant were negative.
Autopsy results were unremarkable, except for the lung parenchyma,
which was dark red, poorly aerated, and oozing blood.

       Active case finding has identified two potential additional
cases in the Chicago area. A case-control study is in progress to
determine risk factors for acute pulmonary hemorrhage among infants. A
similar case-control study was initiated in Cleveland in November
1994.

Reported by: ME Wylam, MD, L Lester, MD, HV Connolly, MD, Wyler
Children's Hospital; S McColley, MD, Children's Memorial Hospital; P
Diaz, MD, W Addington, MD, B Paul, MD, H Guerrero, MBA, U Samala, MPH,
S Whitman, PhD, G Good, MS, R Lee, S Arrowsmith, R Holcombe, S
Lincoln, M Jordan-Williams, Chicago Dept of Public Health; K Scott,
MD, Cook County Dept of Public Health; E Donoghue, MD, B Lifshultz,
MD, Office of the Medical Examiner, County of Cook, Chicago; JR
Lumpkin, MD, BJ Francis, MD, State Epidemiologist, Illinois Dept of
Public Health; DO Hryhorczuk, MD, L Curtis, MS, Univ of Illinois at
Chicago School of Public Health. Div of Reproductive Health, National
Center for Chronic Disease Prevention and Health Promotion; Div of
Environmental Hazards and Health Effects, and Div of Environmental
Health Laboratory Sciences, National Center for Environmental Health;
Div of Field Epidemiology, Epidemiology Program Office, CDC.

Editorial Note: The cluster of cases of acute pulmonary hemorrhage
among infants in Chicago was identified as a result of active
case-finding efforts during the investigation of a similar cluster
identified in Cleveland during November 1994 (1). Patients in both
clusters have been aged less than 1 year, predominantly black, and
previously healthy. Unlike the infants in Cleveland, however, the
residences of the infants in Chicago were not tightly clustered
geographically in one area of the city. In addition, abundant
hemosiderin-laden macrophages, indicative of continued pulmonary
hemorrhage, were not identified in the bronchial aspirates of the
infants in Chicago. However, for six of the infants who underwent
bronchoscopy, the procedure was performed within 2 weeks of the
initial presentation with pulmonary hemorrhage, and hemosiderin-laden
macrophages may not yet have been present.

       Of the seven cases in Chicago, six were in blacks--a finding
that may be associated with socioeconomic status or with the
prevalence of other specific risks, for which race is most likely a
marker. Other factors being assessed through the case-control study
include infant feeding practices, child-care practices, family medical
histories, occupational exposures, environmental exposures, and
animal/rodent exposures. In addition, through collection of clinical
data, the investigation will include assessment of potential
hematologic, allergenic, and genetic etiologies.

       Pulmonary hemorrhage is most commonly a complication of other
conditions, such as cardiac defects, vascular malformations,
neoplasms, infection, milk protein allergies, and immune complex
disorders (2,3), and occurs only rarely among infants. Physicians
should report possible cases through state health departments to CDC's
Air Pollution and Respiratory Health Branch, Division of Environmental
Hazards and Health Effects, National Center for Environmental Health;
telephone (404) 488-7320; fax (404) 488-7335; Internet:
rae1@cehdeh1.em.cdc.gov.

       References

       1. CDC. Acute pulmonary hemorrhage/hemosiderosis among
infants-- Cleveland, January 1993-November 1994. MMWR 1994;43:881-3.

       2. Levy J, Wilmott R. Pulmonary hemosiderosis. In: Hilman BC,
ed. Pediatric respiratory disease: diagnosis and treatment.
Philadelphia: WB Saunders Co., 1993:543-9.

       3. Kumar SR, Rosner IK, Godwin T, Rappaport I. Pulmonary
hemorrhage in a young infant. Ann Allergy 1989;62:168-211.


       Epidemiologic Notes and Reports
       Transmission of Pertussis from Adult to Infant -- Michigan,
       1993

       During 1993, a total of 6586 pertussis cases was reported in
the United States, including 675 (10%) cases among persons aged
greater than 19 years. However, the total number of cases probably was
substantially higher because only an estimated 10% of all pertussis
cases are reported (1); underreporting is greater among adults, who
often have only a mild cough. This report summarizes the investigation
of two cases of pertussis in which transmission occurred from an adult
resident of Massachusetts who was visiting the residence of an infant
in Michigan.

       Patient 1. On October 11, 1993, a 4-month-old boy in Ann Arbor,
Michigan, developed a mild cough. His symptoms gradually worsened
during the following 2 weeks with paroxysms of cough associated with
whooping, vomiting, and apnea. A culture of a nasopharyngeal specimen
obtained on October 25 yielded Bordetella pertussis. On September 8,
the infant had received one dose of diphtheria and tetanus toxoids and
pertussis vaccine (DTP). Treatment for the infant and chemoprophylaxis
of his household contacts with erythromycin were initiated on October
27 and continued for 2 weeks. Although hospitalization was not
required, the infant had a persistent cough for 3 months. The infant
had not attended group day care.

       Patient 2. During September 17-20, 1993, the infant's
47-year-old aunt from Cambridge, Massachusetts, had visited his home.
During the visit, she developed a mild cough. On return to
Massachusetts, her cough worsened, and she developed paroxysms of
cough with inspiratory whoop and posttussive apnea. On September 23,
bronchitis was diagnosed, and she was treated with codeine. On
September 29, therapy with a 7-day course of erythromycin and a
steroid inhalant was initiated. Because of the history of close
contact with her nephew--in whom a culture-confirmed case of pertussis
had been diagnosed--on November 17, a serum sample was obtained for
immunoglobulin G (IgG) antibody to pertussis toxin; the serum IgG
concentration was greater than 30 ug/mL*. Inhalant therapy was
discontinued, and a 14-day course of erythromycin was prescribed for
the patient and three household contacts.

Reported by: ED Mokotoff, MPH, Disease Surveillance Section, RA Dunn,
MD, Immunization Section, DR Johnson, MD, Disease Control Div, KR
Wilcox, Jr, MD, State Epidemiologist, Michigan Dept of Public Health.
L Burger, MPH, S Lett, MD, Immunization Program, Massachusetts Dept of
Public Health. Div of Epidemiology and Surveillance, National
Immunization Program, CDC.

Editorial Note: The investigation of the two cases described in this
report indicates the continuing occurrence of pertussis in adults and
that adults can be a source of pertussis infection for susceptible
infants. Health-care providers should consider pertussis in the
differential diagnoses for acute cough of greater than or equal to 7
days' duration in adults, particularly if the cough is paroxysmal and
associated with posttussive vomiting and/or whooping. Although the
cough associated with pertussis in adults generally is mild (3), the
case in this report indicates that classic symptoms of pertussis
(e.g., paroxysms of cough, posttussive whoop, and apnea) can occur in
adults.

       Laboratory confirmation of pertussis can be difficult because
of the low sensitivity of microbiologic cultures and the occurrence of
false results from direct fluorescent antibody tests. Serodiagnosis
and recently developed polymerase chain reaction tests may be useful
for diagnosis, particularly in persons with a mild cough. However,
these tests have not been standardized and are not widely available.

       Transmission of pertussis can be reduced with prompt diagnosis
and treatment of cases and early administration of chemoprophylaxis to
close contacts (4). Administration of erythromycin for 14 days is
recommended for persons with pertussis and all their household
contacts (regardless of age or vaccination status) and is an important
method of protecting children aged less than 6 months who are too
young to have received the initial three-dose series of DTP
recommended during infancy (5,6). Chemoprophylaxis of household
contacts with erythromycin should be administered as soon as possible
after first contact with a primary case; chemoprophylaxis administered
greater than or equal to 21 days after first contact is considered of
limited value (7).

       References

       1. Sutter RW, Cochi SL. Pertussis hospitalization and mortality
in the United States, 1985-1988. JAMA 1992;267:386-91.

       2. Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in
Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine
effectiveness. J Infect Dis 1994;169:1297-305.

       3. Bass JW. Pertussis: current status of prevention and
treatment. Pediatr Infect Dis 1985;4:614-9.

       4. Sprauer MA, Cochi SL, Zell ER, et al. Prevention of
secondary transmission of pertussis in households with early use of
erythromycin. Am J Dis Child 1992;146:177-81.

       5. ACIP. Diphtheria, tetanus, and pertussis: recommendations
for vaccine use and other preventive measures--recommendations of the
Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(no.
RR-10).

       6. American Academy of Pediatrics. Pertussis. In: Peter G, ed.
1994 Red book: report of the Committee on Infectious Diseases. 23rd
ed. Elk Grove Village, Illinois: American Academy of Pediatrics,
1994:355-67.

       7. Health and Welfare Canada. Pertussis consensus conference.
In: Canada communicable disease report. Vol 19-16. Ottawa: Health and
Welfare Canada, 1993:124-35.

       * Since 1987, the Massachusetts Public Health Biologic
         Laboratory has performed an indirect enzyme-linked
         immunosorbent assay for IgG to pertussis toxin for diagnosis
         of pertussis among persons aged greater than or equal to 11
         years. A serum antipertussis toxin concentration of greater
         than or equal to 20 ug/mL in one specimen is considered by
         public health authorities in Massachusetts as evidence of
         recent infection with B. pertussis (2).


       Current Trends
       Controlling Lead Toxicity in Bridge Workers -- Connecticut,
       1991-1994

       Workers involved in the repair of infrastructure--including
bridges and roads--are at risk for exposure to lead and lead poisoning
(1,2). Because of these risks, in 1990, the Yale University School of
Medicine, the Connecticut Department of Public Health and Addiction
Services (CDPHAS), the Connecticut Department of Transportation
(CONNDOT), and CDC's National Institute for Occupational Safety and
Health (NIOSH) initiated the Connecticut Road Industry Surveillance
Project (CRISP)* to reduce lead toxicity in bridge workers through the
incorporation of protective measures into contracts in addition to the
use of regulatory measures. This report describes an assessment of the
impact of this program.

       The two principal elements of CRISP are 1) detailed medical and
environmental specifications (e.g., medical examinations and
industrial hygiene) for monitoring and reducing occupational lead
exposures at bridge sites--these specifications are included in the
construction contracts and are paid for by CONNDOT under the terms of
the contract; and 2) a centralized, statewide surveillance system to
monitor blood lead levels (BLLs) in workers--this system is based in
CDPHAS.

       Since 1993, CONNDOT has mandated that, for jobs associated with
potential lead exposures, both the bids and contracts explicitly
address lead-control activities, including the need for an industrial
hygienist to monitor every project, personal and ambient airborne lead
sampling, minimum standards for protective equipment, and standardized
comprehensive medical monitoring (using the CRISP protocol). Medical
examinations must be conducted at designated CRISP-affiliated clinics
and blood lead specimens analyzed at a single, specified Occupational
Safety and Health Administration (OSHA)-approved laboratory. CRISP
centralizes the collection and review of comprehensive medical data
for exposed workers and the response when workers' BLLs exceed
specific action levels. Lead-control specifications were fully
implemented in all CONNDOT contracts in February 1993. CRISP had
enrolled some workers before 1993; however, most of these workers were
employed by construction companies that were voluntarily and
independently attempting to protect workers from lead exposures.**
However, since February 1993, all workers potentially exposed to lead
at CONNDOT bridge repair sites have been enrolled in CRISP.

       From July 1991 through December 1994, a total of 1421 workers
were enrolled in the CRISP database; 34 workers were monitored in
1991, 108 in 1992, 669 in 1993, and 959 in 1994***. These workers were
employed by 90 contractors and other companies and were assigned to
projects at 68 CONNDOT sites.

       BLLs for the most highly exposed work categories declined
substantially during 1991-1993 and remained relatively stable during
1994 (Table 1). Average BLLs in painters/blasters declined from 41.8
ug/dL and 28.2 ug/dL in 1991 and 1992, respectively, to 16.4 ug/dL and
16.6 ug/dL in 1993 and 1994,**** respectively. Similarly, average BLLs
for iron workers/welders declined steadily from 20.6 ug/dL in 1991 to
10.9 ug/dL in 1994, and those for carpenters from 14.0 ug/dL in
1992***** to 7.5 ug/dL in 1994.

Reported by: KF Maurer, MD, MR Cullen, MD, Occupational and
Environmental Medicine Program, Yale Univ School of Medicine, New
Haven; M Erdil, MD, Immediate Medical Care Center, Weathersfield; CJ
Dupuy, MS, BC Jung, MPH, JL Hadler, MD, State Epidemiologist,
Connecticut Dept of Public Health and Addiction Svcs; B Castler,
Connecticut Dept of Transportation. SK Hammond, PhD, School of Public
Health, Univ of California, Berkeley. Div of Surveillance, Hazard
Evaluations, and Field Studies, National Institute for Occupational
Safety and Health, CDC.

Editorial Note: Although the potential for high exposures to lead
among bridge repair workers was well documented in 1982 (3), limited
progress has been made in controlling exposures. In 1991, NIOSH
reported elevated airborne lead exposures and BLLs in bridge repair
workers at eight sites in five states and recommended improved
surveillance for and more effective control of lead exposures at such
sites (4). During 1988-1991, efforts by clinicians and industrial
hygienists in Connecticut confirmed high lead exposures and high BLLs
among bridge workers in certain job categories (5). In May 1993, OSHA
lowered the permissible exposure level for lead in the construction
industry (previously 200 ug/m superscript 3) to that established for
general industry (50 ug/m superscript 3) (6). One of the national
health objectives for the year 2000 is to eliminate exposures
associated with BLLs greater than 25 ug/dL in workers (objective 10.8)
(7).

       In Connecticut, extensive bridge repair and rehabilitation
began statewide in 1983 after the collapse of an interstate highway
bridge. The presence of lead-containing paints on most bridges created
the potential for high exposures to lead for many workers. CRISP is an
innovative approach for workers and their employers to control lead
exposures on bridge repair jobs and, compared with traditional
surveillance and regulatory approaches, is unique in its routine use
of health-related contract language and its focus on medical
surveillance--an approach that emphasizes a collaborative,
nonadversarial strategy for exposure control.

       The use of contract language as a foundation for health and
safety activity in the construction industry ensures worker protection
through direct, day-to-day enforcement by the contracting parties. For
example, for bridge repair projects, CONNDOT inspectors and field
engineers enforce the requirements of the "Lead Health Protection
Program" (as it is termed in the contracts) just as they do the
thickness of paint applied or other construction specifications.

       The medical focus and regional organization of CRISP were
designed to address the specific circumstances of the construction
industry, in which workers frequently transfer sites, change
employers, or move to different regions. The requirement that all
clinics adhere to a standard medical protocol and the centralization
of all medical decision making for bridge workers ensures that
CONNDOT's contractors and their employees receive a consistent
standard for medical care and work- and exposure-related decisions. In
addition, because medical data are relayed to the central CRISP office
within 48-72 hours of medical evaluation and testing for BLL, CRISP
staff can respond rapidly to reports of elevated BLLs with
recommendations to reduce or eliminate further exposures to the
affected worker or to address adverse exposure-related health effects.

       The findings in this report indicate that after implementation
of CRISP, BLLs decreased substantially among Connecticut bridge
workers. Evaluation of these results is complicated by the concurrent
promulgation (in 1993) by OSHA of the Interim Final Standard for Lead
in Construction (29 CFR 1926.62) (6), a comprehensive standard for
lead control in the construction industry. The relative contributions
of these efforts in reducing BLLs are even more difficult to clarify
because some provisions of the CONNDOT "Lead Health Protection
Program" contain more aggressive worker exposure-control requirements
than does the OSHA standard (e.g., CRISP mandates more frequent BLL
monitoring during the initial months of a project than does OSHA). In
addition, CRISP, CONNDOT, and OSHA allow CRISP-enrolled employers 30
days to correct problems on their sites before a formal referral to
OSHA is made from CRISP/CONNDOT; this agreement assists CRISP in
encouraging compliance from companies and enables OSHA to more
effectively target problem sites for inspection.

       References

       1. CDC. Lead poisoning in bridge demolition
workers--Massachusetts. MMWR 1989;38:687-8,693-4.

       2. CDC. Lead poisoning in bridge demolition workers--Georgia,
1992. MMWR 1993;42:388-90.

       3. Landrigan PJ, Baker EL Jr, Himmelstein JS, Stein GF, Weddig
JP, Straub WE. Exposure to lead from the Mystic River Bridge: the
dilemma of deleading. N Engl J Med 1982;306:673-6.

       4. NIOSH. Request for assistance in preventing lead poisoning
in construction workers. Cincinnati: US Department of Health and Human
Services, Public Health Service, CDC, 1990; DHHS publication no.
(NIOSH)91-116a. (Revised 1992).

       5. Maurer KF, Smith IK, Cullen MR. Controlling lead toxicity in
bridge workers: preliminary findings of the Connecticut Road Industry
Surveillance Project. Journal of Protective Coatings and Linings
1993;10:37-43.

       6. Occupational Safety and Health Administration, US Department
of Labor. Lead exposure in construction: interim final rule. Federal
Register 1993;58:26590-649. (29 CFR 1926).

       7. Public Health Service. Healthy people 2000: national health
promotion and disease prevention objectives--full report, with
commentary. Washington, DC: US Department of Health and Human
Services, 1991; DHHS publication no. (PHS)91-50212.

            * CRISP is funded through a cooperative agreement between
              NIOSH and the Yale University School of Medicine.

          ** For this reason, CRISP data from 1991 and 1992 may not be
             representative of all Connecticut lead-exposed bridge
             workers during that time; however, comparison of CRISP
             data from subsequent years with these data would most
             likely underestimate reductions in BLLs resulting from
             CRISP activities.

         *** The same worker may have been monitored in greater than 1
             year and would, therefore, be counted in the total for
             each year in which he or she was monitored.

        **** BLL data for 1994 are complete through September 30,
             1994.

       ***** No carpenters were enrolled in the system in 1991.


       Erratum: Vol. 44, No. 3

       In the notice to readers "Availability of Electronic MMWR on
Internet," the information in the box by the first bullet on page 49
should be http://www.cdc.gov/ instead of as published. *

       DISTRIBUTED BY GENA/aegis, your online global gateway to a
       world of people, information, and resources.  714.248.2836 *
       8N1/Full Duplex * v.34
